http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012141989-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_083c3929b391d2cebac269c294a75d84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_04d9826a00dc6aaf2f479b909323481b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a416da301af6529e8ad52a5249e6445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22e3d94bba714fc85287d5e2a8116e57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89f6186da1bf0f6d5c4af7ab4ebaae75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c4322cb4de342be2dbedcbe0c278f6f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2812
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
filingDate 2012-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f436fb3cdad66a82faee0dd309226ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1f65fae81572f92a3435007241f4e15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9490a92b83282c3902f8cbf97d8d7422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da00851ac5e9b3703244e3f479943dad
publicationDate 2012-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012141989-A2
titleOfInvention Immunogens
abstract The present invention relates, in general, to HIV and, in particular, to novel immunogens suitable for use in inducing an immune response to HIV.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2912055-A4
priorityDate 2011-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008213296-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3002
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100000986
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9544
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14939
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49357
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281731
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73755215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3671
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C782
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID64006
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C781
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID171528
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP18291
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417282
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID57667
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9544
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID57667
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP10144
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57134040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428545465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395375
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11676

Total number of triples: 55.